Literature DB >> 16979191

Characterization of the transient receptor potential channels mediating lysophosphatidic acid-stimulated calcium mobilization in B lymphoblasts.

Angela S Roedding1, Peter P Li, Jerry J Warsh.   

Abstract

Altered 1-oleoyl-lysophosphatidic acid (LPA, 100 microM)-stimulated calcium responses occur in B-lymphoblast cell lines from bipolar disorder patients, but the mechanism(s) involved is uncertain. Lysophosphatidic acid shares a structurally similar fatty acid side chain with the diacylglycerol analogue, 1-oleoyl-2-acetyl-sn-glycerol (OAG), a known activator of subtypes 3, 6 and 7 of the canonical transient receptor potential (TRPC) cation channel subfamily. Accordingly, the objective of this study was to determine whether the LPA-stimulated calcium response in B-lymphoblasts is mediated, in part, through this TRPC channel subfamily. Divalent cation selectivity in response to thapsigargin, LPA and OAG were used to distinguish TRPC-like character of the responses to these agents in BLCLs. The sensitivity to gadolinium, an inhibitor of capacitative calcium channels, was used to determine the store-operated nature of the responses. The TRPC isoforms that are present in BLCLs as identified by immunoblotting and/or PCR include TRPC1, 3 and 5. Minimal barium influx in calcium-free buffer was observed following thapsigargin stimulation. However, LPA stimulated barium influx of a magnitude similar to that induced by OAG. Thapsigargin-provoked calcium influx was completely inhibited by gadolinium (10 microM), whereas LPA and OAG-stimulated responses were partially inhibited and potentiated, respectively. The results suggest that 100 microM LPA stimulates calcium entry through channels with characteristics similar to TRPC3, as TRPC6 and 7 are absent in B-lymphoblasts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979191     DOI: 10.1016/j.lfs.2006.08.021

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes.

Authors:  Soizic Garaud; Taher E Taher; Marjolaine Debant; Miguel Burgos; Sarra Melayah; Christian Berthou; Kaushal Parikh; Jacques-Olivier Pers; Damien Luque-Paz; Gilles Chiocchia; Maikel Peppelenbosch; David A Isenberg; Pierre Youinou; Olivier Mignen; Yves Renaudineau; Rizgar A Mageed
Journal:  Cell Mol Immunol       Date:  2016-08-08       Impact factor: 11.530

2.  Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site.

Authors:  Andrés Nieto-Posadas; Giovanni Picazo-Juárez; Itzel Llorente; Andrés Jara-Oseguera; Sara Morales-Lázaro; Diana Escalante-Alcalde; León D Islas; Tamara Rosenbaum
Journal:  Nat Chem Biol       Date:  2011-11-20       Impact factor: 15.040

3.  Phospholipase C-independent effects of 3M3FBS in murine colon.

Authors:  Laura Dwyer; Hyun Jin Kim; Byoung Ho Koh; Sang Don Koh
Journal:  Eur J Pharmacol       Date:  2009-11-18       Impact factor: 4.432

4.  A critical role for the transient receptor potential channel type 6 in human platelet activation.

Authors:  Hari Priya Vemana; Zubair A Karim; Christine Conlon; Fadi T Khasawneh
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

5.  Genome-wide association study identifies shared risk loci common to two malignancies in golden retrievers.

Authors:  Noriko Tonomura; Ingegerd Elvers; Rachael Thomas; Kate Megquier; Jason Turner-Maier; Cedric Howald; Aaron L Sarver; Ross Swofford; Aric M Frantz; Daisuke Ito; Evan Mauceli; Maja Arendt; Hyun Ji Noh; Michele Koltookian; Tara Biagi; Sarah Fryc; Christina Williams; Anne C Avery; Jong-Hyuk Kim; Lisa Barber; Kristine Burgess; Eric S Lander; Elinor K Karlsson; Chieko Azuma; Jaime F Modiano; Matthew Breen; Kerstin Lindblad-Toh
Journal:  PLoS Genet       Date:  2015-02-02       Impact factor: 5.917

6.  Decreased levels of canonical transient receptor potential channel 3 protein in the rat cerebral cortex after chronic treatment with lithium or valproate.

Authors:  Sasan Zaeri; Shirin Farjadian; Masoumeh Emamghoreishi
Journal:  Res Pharm Sci       Date:  2015 Sep-Oct

7.  Lysophosphatidic acid promotes cell migration through STIM1- and Orai1-mediated Ca2+(i) mobilization and NFAT2 activation.

Authors:  Ralph Jans; Laura Mottram; Darren L Johnson; Anna M Brown; Stephen Sikkink; Kehinde Ross; Nick J Reynolds
Journal:  J Invest Dermatol       Date:  2012-10-25       Impact factor: 8.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.